Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

F-Star Therapeutics Inc (NQ: FSTX )

2.380 +0.040 (+1.71%)
Streaming Delayed Price Updated: 3:59 PM EDT, May 17, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 249,828
Open 2.390
Bid (Size) 2.300 (2)
Ask (Size) 2.620 (6)
Prev. Close 2.340
Today's Range 2.300 - 2.500
52wk Range 2.070 - 9.710
Shares Outstanding 21,493,212
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Recap: F-star Therapeutics Q1 Earnings
F-star Therapeutics (NASDAQ:FSTX) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2022
Upgrades Loop Capital upgraded the previous rating for Aspen Technology Inc (NASDAQ:AZPN) from Hold to Buy. In the second quarter, Aspen Technology showed an EPS of $1.20,... 
Via Benzinga

Performance

YTD
-55.60%
-55.60%
1 Month
-20.13%
-20.13%
3 Month
-34.97%
-34.97%
6 Month
-62.99%
-62.99%
1 Year
-64.69%
-64.69%

More News

Read More
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Via Benzinga
Exposures Product Safety
Earnings Scheduled For March 14, 2022
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
Via Benzinga
Peering Into F-star Therapeutics Recent Short Interest
Via Benzinga
F-star Shares Rise On Bispecific Antibody Therapeutics Pact With Janssen
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Via Benzinga
F-star's FS118 Development Program To Include Checkpoint Naïve Cancer Patients
Via Benzinga
66 Biggest Movers From Yesterday
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why F-Star Therapeutics Shares Are Trading Higher Today
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
F-star Therapeutics Stock Jumps On Licensing Pact For STING Inhibitors With AstraZeneca
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Via Benzinga
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2021
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
48 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.